Medical statistics

Introducing Emma Up: A Revolutionary Sleep Solution Powered By Action-Oriented AI Coaching

Retrieved on: 
Friday, March 1, 2024

NEW YORK, March 1, 2024 /PRNewswire/ -- Emma Up, the AI sleep coaching app created by Emma - The Sleep Company (the world's largest D2C sleep brand), is excited to announce the launch of its new sound-based sleep tracking feature. This innovative addition utilizes AI technology to offer users comprehensive insights into their sleep patterns and lifestyle habits without the need for any additional devices.

Key Points: 
  • Emma Up, a revolutionary AI sleep coaching app, launches a new sound-based sleep tracking function providing users with personalized lifestyle insights and actionable next steps for improving sleep quality.
  • NEW YORK, March 1, 2024 /PRNewswire/ -- Emma Up, the AI sleep coaching app created by Emma - The Sleep Company (the world's largest D2C sleep brand), is excited to announce the launch of its new sound-based sleep tracking feature.
  • Developed in collaboration with sleep experts from Oxford University, Emma Up stands as the most advanced sleep app on the market.
  • [3]
    Additionally, Emma Up acts as an AI sleep coach and pioneers that technology: expect hyper-personalized programs tailored to each user's unique sleep patterns, habits, and lifestyle.

National Safety Council Estimates Traffic Crashes Took More Than 44,000 Lives in 2023

Retrieved on: 
Monday, February 26, 2024

WASHINGTON, Feb. 26, 2024 /PRNewswire/ -- Preliminary analysis from the National Safety Council shows motor vehicle fatalities in the United States remain at a devastatingly high level, as an estimated 44,450 people died in traffic crashes in 2023. While it marks a 4% decline from 2022, compared to pre-pandemic 2019, it's a 13.6% uptick, further demonstrating the seriousness of this public health crisis.

Key Points: 
  • WASHINGTON, Feb. 26, 2024 /PRNewswire/ -- Preliminary analysis from the National Safety Council shows motor vehicle fatalities in the United States remain at a devastatingly high level, as an estimated 44,450 people died in traffic crashes in 2023 .
  • Safety issues such as speeding, distracted and impaired driving are all contributing factors to the tens of thousands of people lost in preventable crashes on U.S. roads each year.
  • Embracing the Safe System Approach at national, state and local levels is a critical step toward eliminating traffic fatalities nationwide.
  • The National Safety Council has calculated traffic fatality estimates since 1913.

Prevent Blindness Launches New "Retinopathy of Prematurity (ROP) Education and Support Program" as Part of Inaugural ROP Awareness Week, Feb. 26 - March 3, 2024

Retrieved on: 
Wednesday, February 21, 2024

CHICAGO, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye health and safety nonprofit organization, has launched the new "Retinopathy of Prematurity Education and Support Program," as part of its first ROP Awareness Week, declared Feb. 26 – March 3, 2024. The group is offering a variety of free educational resources to the public and professionals, including fact sheets, social media graphics in English and Spanish, dedicated online resources, and a new video series.

Key Points: 
  • "Diagnosing and treating ROP early is essential for preventing or lessening ROP-associated vision loss," said Jeff Todd, president and CEO of Prevent Blindness.
  • To help address the need for ROP awareness and education, Prevent Blindness convened leading organizations in the parent support, education, and advocacy arenas to partner on creating the ROP Education and Support Program.
  • The ROP Education and Support Program and ROP Awareness Week is supported by funding from Regeneron .
  • In the Prevent Blindness Focus on Eye Health Expert Series, " Retinopathy of Prematurity ," Jeff Todd, president and CEO of Prevent Blindness, interviews R.V.

Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID

Retrieved on: 
Tuesday, January 2, 2024

The FDA agreed that for the planned Phase 2 proof-of-concept study, Virios can use fatigue as the primary endpoint and orthostatic intolerance as a key secondary endpoint to assess the effectiveness of IMC-2 in treating PASC.

Key Points: 
  • The FDA agreed that for the planned Phase 2 proof-of-concept study, Virios can use fatigue as the primary endpoint and orthostatic intolerance as a key secondary endpoint to assess the effectiveness of IMC-2 in treating PASC.
  • The FDA recommended assessment of a range of IMC-2 doses, including valacyclovir doses above presently approved dosage strengths, to ensure effective inhibition of reactivated herpesvirus.
  • Following the receipt of the FDA’s feedback, Virios is currently exploring options to advance the IMC-2 LC Phase 2 research program.
  • IMC-2 has the potential to be one of the first approved treatments specifically for LC.

National Safety Council Estimates 21,150 People Died on U.S. Roads in First Half of 2023

Retrieved on: 
Wednesday, August 23, 2023

WASHINGTON, Aug. 23, 2023 /PRNewswire/ -- Preliminary estimates released by the National Safety Council show traffic deaths in the U.S. are on a slight decline through the first six months of 2023, as compared to the same period in 2022. From January 2023 through June 2023, an estimated 21,150 people died in preventable motor vehicle crashes in the United States, down 3% from the first six months of last year.

Key Points: 
  • From January 2023 through June 2023, an estimated 21,150 people died in preventable motor vehicle crashes in the United States, down 3% from the first six months of last year.
  • "While there is a glimmer of hope that progress is being made, these estimates are still a stark reminder of the work that lies ahead," said Mark Chung, executive vice president of roadway practice at the National Safety Council.
  • The estimates further underscore the urgent need for continued efforts to improve road safety across the nation through the implementation of the Safe System approach ."
  • NSC motor vehicle fatality estimates and supplemental estimate information, including estimates for each state, can be found here .

Employers Who Give Birthday Gifts Have Higher Company Morale and Employee Retention, According to Snappy's 2023 Birthday Study

Retrieved on: 
Monday, August 7, 2023

NEW YORK, Aug. 7, 2023 /PRNewswire/ -- Today, Snappy, the award-winning gifting company for both business gifting and personal gifting, releases findings from Unwrapped: Snappy's 2023 Birthday Study, an in-depth report examining how Americans want to celebrate and be celebrated each year.

Key Points: 
  • The majority of working Americans agree that "if employers celebrated personal milestones such as birthdays, employee morale would be higher in the workplace" (80.8%), as would employee retention (74.6%).
  • The top way to celebrate a birthday, according to the study, is by eating cake or another sweet treat (67.2%).
  • The majority of Americans agree, "if employers celebrated personal milestones such as birthdays, employee morale would be higher in the workplace" (80.8%), as would employee retention (74.6%).
  • When buying gifts for their own child, Americans report spending an average of $72.39 on birthday gifts.

New Studies Show Daily Prune Consumption Supports Cardiovascular Health in Aging Population

Retrieved on: 
Monday, July 24, 2023

"We want to advance the research on this topic area to better understand how prune consumption relates to cardiometabolic health outcomes, especially in the aging population that often experiences an elevated risk for cardiovascular disease."

Key Points: 
  • "We want to advance the research on this topic area to better understand how prune consumption relates to cardiometabolic health outcomes, especially in the aging population that often experiences an elevated risk for cardiovascular disease."
  • "It is exciting to see research on prune consumption and cardiovascular health expand," says Andrea N. Giancoli, MPH, RDN, Nutrition Advisor, California Prune Board.
  • These two studies represent the latest additions of research on prune consumption and human health.
  • Previous research has shown that daily prune consumption can help support gut health, bone health, and weight management.

Peace Education Program at Rehabilitation Centers in South Africa & Globally

Retrieved on: 
Tuesday, July 11, 2023

LOS ANGELES, July 11, 2023 /PRNewswire-PRWeb/ -- From Substance Abuse to Self-Respect

Key Points: 
  • At rehabilitation centers in Johannesburg, South Africa and beyond, the remarkable success of The Prem Rawat Foundation's Peace Education Program in helping with alcohol and drug abuse treatment is "a dream come true."
  • Many of these individuals say the Peace Education Program enables them to discover their inner-strength, have self-respect, feel empathy and accept responsibility.
  • Amazed by the change in himself, Benin, a participant in the Peace Education Program at the TAG Center in Johannesburg, South Africa, felt moved to help facilitate the program for others.
  • The Peace Education Program is an innovative series of video-based workshops that help people discover their own inner strength and personal peace.

DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico

Retrieved on: 
Tuesday, June 27, 2023

DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.

Key Points: 
  • DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
  • The Mexico City Prospective Study reflects a long-standing collaboration between Universidad Nacional Autónoma de México (UNAM) and Oxford Population Health.
  • “Our work with Oxford Population Health, DNAnexus, and AWS presents a unique opportunity for researchers in Mexico to advance medical research for the people of Mexico,” said Jesús Alegre-Díaz, Professor of Epidemiology at UNAM and Principal Investigator for the Mexico City Prospective Study.
  • “From this Mexico Prospective Study to the UK Biobank to Our Future Health, the DNAnexus platform continues to be the trusted platform of choice for the world’s largest biomedical research programs.

Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain

Retrieved on: 
Thursday, May 4, 2023

The Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study will evaluate the safety and efficacy of SP-103 (lidocaine topical system) 5.4% in subjects with moderate to severe acute lower back pain (LBP).

Key Points: 
  • The Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study will evaluate the safety and efficacy of SP-103 (lidocaine topical system) 5.4% in subjects with moderate to severe acute lower back pain (LBP).
  • The trial is to enroll approximately 80 patients at 10 sites across the U.S. with acute LBP.
  • Scilex is developing SP-103 to be a triple-strength, non-aqueous lidocaine topical system for the treatment of acute LBP.
  • The outcome of the Phase 2 study should enable planning of a subsequent Pivotal Phase 3 trial.